Table 2 |
|||||||
|
Prostasin mRNA levels in normal and affected tissues. |
|||||||
|
Variable |
mRNA level in normal tissue Mean (SD) |
Pa |
mRNA level in adenomas/carcinomas Mean (SD) |
Pa |
Pb |
||
|
|
|||||||
|
Prostasin |
|||||||
|
|
|||||||
|
Healthy individuals |
0.96 (0.29) |
||||||
|
|
|||||||
|
Mild/moderate |
1.10 (0.38) |
NS |
0.62 (0.24) |
NS |
<0.001 |
||
|
|
|||||||
|
Severe |
1.08 (0.46) |
NS |
0.73 (0.50) |
NS |
<0.01 |
||
|
|
|||||||
|
Carcinoma distant adjacent |
0.85 (0.65) |
NS |
0.61 (0.60) |
NS |
<0.05 |
||
|
0.90 (0.76) |
NS |
<0.01 |
|||||
|
|
|||||||
|
All adenomas and carcinomas |
0.96 (0.61) |
NS |
0.62 (0.48) |
<0.05 |
ND |
||
|
|
|||||||
|
PN-1 |
|||||||
|
|
|||||||
|
Healthy individual |
0.022 (0.030) |
||||||
|
|
|||||||
|
Mild/moderate |
0.015 (0.017) |
NS |
0.041 (0.028) |
NS |
<0.001 |
||
|
|
|||||||
|
Severe |
0.010 (0.003) |
NS |
0.033 (0.031) |
NS |
<0.05 |
||
|
|
|||||||
|
Carcinoma distant adjacent |
0.028 (0.027) |
NS |
0.063 (0.060) |
<0.001 |
<0.001 |
||
|
0.025 (0.018) |
NS |
<0.001 |
|||||
|
|
|||||||
|
The mRNA levels were normalised to β-actin mRNA levels. NS = not significant ND = not determined p value for the comparison to the expression levels in healthy individuals using a one-way ANOVA and Tukey's post test for paired comparisons. a) p value for the comparison to the expression levels in healthy individuals using a one-way ANOVA and Tukey's post test for paired comparisons. b) p value for the comparison of the expression levels in normal and affected tissue from the same individual using a paired t-test |
|||||||
|
Selzer-Plon et al. BMC Cancer 2009 9:201 doi:10.1186/1471-2407-9-201 |
|||||||